-
1
-
-
0030049390
-
Prostaglandin synthase 2
-
Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125-40.
-
(1996)
Biochim Biophys Acta
, vol.1299
, pp. 125-140
-
-
Herschman, H.R.1
-
2
-
-
0029008617
-
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
-
Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
-
(1995)
Cancer Res
, vol.55
, pp. 2556-2559
-
-
Kargman, S.L.1
O'Neill, G.P.2
Vickers, P.J.3
Evans, J.F.4
Mancini, J.A.5
Jothy, S.6
-
3
-
-
0037307483
-
Cyclooxygenase 2: A molecular target for cancer prevention and treatment
-
Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003;24:96-102.
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 96-102
-
-
Subbaramaiah, K.1
Dannenberg, A.J.2
-
4
-
-
0036440486
-
Role of cyclooxygenase-2 in breast cancer
-
Singh B. Lucci A. Role of cyclooxygenase-2 in breast cancer. J Surg Res 2002;108:173-9.
-
(2002)
J Surg Res
, vol.108
, pp. 173-179
-
-
Singh, B.1
Lucci, A.2
-
5
-
-
0037089506
-
Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer
-
Kundu N, Fulton AM. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 2002;62:2343-6.
-
(2002)
Cancer Res
, vol.62
, pp. 2343-2346
-
-
Kundu, N.1
Fulton, A.M.2
-
6
-
-
0034671806
-
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
-
Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000;89:2637-45.
-
(2000)
Cancer
, vol.89
, pp. 2637-2645
-
-
Soslow, R.A.1
Dannenberg, A.J.2
Rush, D.3
Woerner, B.M.4
Khan, K.N.5
Masferrer, J.6
Koki, A.T.7
-
8
-
-
0035877634
-
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44
-
Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 2001;276:20809-12.
-
(2001)
J Biol Chem
, vol.276
, pp. 20809-20812
-
-
Dohadwala, M.1
Luo, J.2
Zhu, L.3
Lin, Y.4
Dougherty, G.J.5
Sharma, S.6
Huang, M.7
Pold, M.8
Batra, R.K.9
Dubinett, S.M.10
-
9
-
-
0030952695
-
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
-
Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 3336-3340
-
-
Tsujii, M.1
Kawano, S.2
Dubois, R.N.3
-
10
-
-
0028803728
-
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
-
Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
-
(1995)
Cell
, vol.83
, pp. 493-501
-
-
Tsujii, M.1
DuBois, R.N.2
-
11
-
-
0032521401
-
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production
-
Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998;58:1208-16.
-
(1998)
Cancer Res
, vol.58
, pp. 1208-1216
-
-
Huang, M.1
Stolina, M.2
Sharma, S.3
Mao, J.T.4
Zhu, L.5
Miller, P.W.6
Wollman, J.7
Herschman, H.8
Dubinett, S.M.9
-
12
-
-
0033979545
-
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
-
Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361-70.
-
(2000)
J Immunol
, vol.164
, pp. 361-370
-
-
Stolina, M.1
Sharma, S.2
Lin, Y.3
Dohadwala, M.4
Gardner, B.5
Luo, J.6
Zhu, L.7
Kronenberg, M.8
Miller, P.W.9
Portanova, J.10
Lee, J.C.11
Dubinett, S.M.12
-
13
-
-
0037343236
-
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function
-
Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, Huang M, Dohadwala M, Batra RK, et al. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res 2003;9:961-8.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 961-968
-
-
Sharma, S.1
Stolina, M.2
Yang, S.C.3
Baratelli, F.4
Lin, J.F.5
Atianzar, K.6
Luo, J.7
Zhu, L.8
Lin, Y.9
Huang, M.10
Dohadwala, M.11
Batra, R.K.12
-
14
-
-
0030589376
-
Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production
-
Huang M, Sharma S, Mao JT, Dubinett SM. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 1996;157:5512-20.
-
(1996)
J Immunol
, vol.157
, pp. 5512-5520
-
-
Huang, M.1
Sharma, S.2
Mao, J.T.3
Dubinett, S.M.4
-
15
-
-
0025924175
-
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
-
Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991;146:108-13.
-
(1991)
J Immunol
, vol.146
, pp. 108-113
-
-
Betz, M.1
Fox, B.S.2
-
16
-
-
0032546352
-
Dendritic cells and the control of immunity
-
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
-
(1998)
Nature
, vol.392
, pp. 245-252
-
-
Banchereau, J.1
Steinman, R.M.2
-
17
-
-
0036570609
-
Dendritic-cell-based anticancer vaccination: Has it matured?
-
Fukao T. Dendritic-cell-based anticancer vaccination: has it matured? Trends Immunol 2002;23:231-2.
-
(2002)
Trends Immunol
, vol.23
, pp. 231-232
-
-
Fukao, T.1
-
18
-
-
20144365496
-
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
-
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention. N Engl J Med 2005;352:1071-80.
-
(2005)
N Engl J Med
, vol.352
, pp. 1071-1080
-
-
Solomon, S.D.1
McMurray, J.J.2
Pfeffer, M.A.3
Wittes, J.4
Fowler, R.5
Finn, P.6
Anderson, W.F.7
Zauber, A.8
Hawk, E.9
Bertagnolli, M.10
-
19
-
-
0018083233
-
Heterogeneity of tumor cells from a single mouse mammary tumor
-
Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978;38:3174-81.
-
(1978)
Cancer Res
, vol.38
, pp. 3174-3181
-
-
Dexter, D.L.1
Kowalski, H.M.2
Blazar, B.A.3
Fligiel, Z.4
Vogel, R.5
Heppner, G.H.6
-
20
-
-
0037446966
-
Transforming growth factor Beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines
-
Kobie JJ, Wu RS, Kurt RA, Lou S, Adelman MK, Whitesell LJ, Ramanathapuram LV, Arteaga CL, Akporiaye ET. Transforming growth factor Beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res 2003;63:1860-4.
-
(2003)
Cancer Res
, vol.63
, pp. 1860-1864
-
-
Kobie, J.J.1
Wu, R.S.2
Kurt, R.A.3
Lou, S.4
Adelman, M.K.5
Whitesell, L.J.6
Ramanathapuram, L.V.7
Arteaga, C.L.8
Akporiaye, E.T.9
-
21
-
-
0029744442
-
Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response
-
Kwak LW, Young HA, Pennington RW, Weeks SD. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA 1996;93:10972-7.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 10972-10977
-
-
Kwak, L.W.1
Young, H.A.2
Pennington, R.W.3
Weeks, S.D.4
-
22
-
-
0013900032
-
Accurate identification of experimental pulmonary metastases
-
Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 1966;36:641-5.
-
(1966)
J Natl Cancer Inst
, vol.36
, pp. 641-645
-
-
Wexler, H.1
-
23
-
-
0022074792
-
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay
-
Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-3.
-
(1985)
Anal Chem
, vol.57
, pp. 1170-1173
-
-
Pradelles, P.1
Grassi, J.2
Maclouf, J.3
-
25
-
-
0038793763
-
GM-CSF-secretina melanoma vaccines
-
Dranoff G. GM-CSF-secretina melanoma vaccines. Oncogene 2003;22:3188-92.
-
(2003)
Oncogene
, vol.22
, pp. 3188-3192
-
-
Dranoff, G.1
-
26
-
-
0036813199
-
GM-CSF-based cancer vaccines
-
Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 2002;188:147-54.
-
(2002)
Immunol Rev
, vol.188
, pp. 147-154
-
-
Dranoff, G.1
-
27
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539-43.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
Jackson, V.7
Hamada, H.8
Pardoll, D.9
Mulligan, R.C.10
-
28
-
-
0036468287
-
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in aneiosenic endothelial cells in vivo
-
Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in aneiosenic endothelial cells in vivo. Cancer Res 2002;62:625-31.
-
(2002)
Cancer Res
, vol.62
, pp. 625-631
-
-
Leahy, K.M.1
Ornberg, R.L.2
Wang, Y.3
Zweifel, B.S.4
Koki, A.T.5
Masferrer, J.L.6
-
29
-
-
0037100867
-
Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer
-
Connolly EM, Harmey JH, O'Grady T, Foley D, Roche-Nagle G, Kay E, Bouchier-Hayes DJ. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer 2002;87:231-7.
-
(2002)
Br J Cancer
, vol.87
, pp. 231-237
-
-
Connolly, E.M.1
Harmey, J.H.2
O'Grady, T.3
Foley, D.4
Roche-Nagle, G.5
Kay, E.6
Bouchier-Hayes, D.J.7
-
30
-
-
0347717578
-
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
-
Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression, Proc Natl Acad Sci USA 2004;101:591-6.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 591-596
-
-
Chang, S.H.1
Liu, C.H.2
Conway, R.3
Han, D.K.4
Nithipatikom, K.5
Trifan, O.C.6
Lane, T.F.7
Hla, T.8
-
31
-
-
0345275867
-
Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy
-
DeLong P, Tanaka T, Kruklitis R, Henry AC, Kapoor V, Kaiser LR, Sterman DH, Albelda SM. Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res 2003;63:7845-52.
-
(2003)
Cancer Res
, vol.63
, pp. 7845-7852
-
-
Delong, P.1
Tanaka, T.2
Kruklitis, R.3
Henry, A.C.4
Kapoor, V.5
Kaiser, L.R.6
Sterman, D.H.7
Albelda, S.M.8
-
32
-
-
2442686929
-
Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice
-
Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice. Cancer Res 2004;64:3668-78.
-
(2004)
Cancer Res
, vol.64
, pp. 3668-3678
-
-
Zeytin, H.E.1
Patel, A.C.2
Rogers, C.J.3
Canter, D.4
Hursting, S.D.5
Schlom, J.6
Greiner, J.W.7
-
33
-
-
0345628580
-
T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice
-
Schuler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med 1999;189:803-10.
-
(1999)
J Exp Med
, vol.189
, pp. 803-810
-
-
Schuler, T.1
Qin, Z.2
Ibe, S.3
Noben-Trauth, N.4
Blankenstein, T.5
|